nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0204	0.0359	CcSEcCtD
Terazosin—Cough increased—Ramipril—type 1 diabetes mellitus	0.0167	0.0293	CcSEcCtD
Terazosin—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.0126	0.0222	CcSEcCtD
Terazosin—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0121	0.0214	CcSEcCtD
Terazosin—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0119	0.021	CcSEcCtD
Terazosin—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0117	0.0205	CcSEcCtD
Terazosin—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.0114	0.0201	CcSEcCtD
Terazosin—Arthritis—Ramipril—type 1 diabetes mellitus	0.0114	0.02	CcSEcCtD
Terazosin—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.0113	0.02	CcSEcCtD
Terazosin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.0113	0.0199	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.011	0.0193	CcSEcCtD
Terazosin—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0101	0.0178	CcSEcCtD
Terazosin—Gastritis—Ramipril—type 1 diabetes mellitus	0.0098	0.0172	CcSEcCtD
Terazosin—Asthma—Ramipril—type 1 diabetes mellitus	0.00957	0.0168	CcSEcCtD
Terazosin—Influenza—Ramipril—type 1 diabetes mellitus	0.00957	0.0168	CcSEcCtD
Terazosin—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00932	0.0164	CcSEcCtD
Terazosin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.0092	0.0162	CcSEcCtD
Terazosin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00881	0.0155	CcSEcCtD
Terazosin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00873	0.0154	CcSEcCtD
Terazosin—Weight increased—Ramipril—type 1 diabetes mellitus	0.00871	0.0153	CcSEcCtD
Terazosin—Jaundice—Ramipril—type 1 diabetes mellitus	0.00831	0.0146	CcSEcCtD
Terazosin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00829	0.0146	CcSEcCtD
Terazosin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00829	0.0146	CcSEcCtD
Terazosin—Sweating—Ramipril—type 1 diabetes mellitus	0.00818	0.0144	CcSEcCtD
Terazosin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00804	0.0142	CcSEcCtD
Terazosin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.008	0.0141	CcSEcCtD
Terazosin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00754	0.0133	CcSEcCtD
Terazosin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00738	0.013	CcSEcCtD
Terazosin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00714	0.0126	CcSEcCtD
Terazosin—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00684	0.012	CcSEcCtD
Terazosin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00667	0.0117	CcSEcCtD
Terazosin—Tension—Ramipril—type 1 diabetes mellitus	0.00654	0.0115	CcSEcCtD
Terazosin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00653	0.0115	CcSEcCtD
Terazosin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00647	0.0114	CcSEcCtD
Terazosin—Tremor—Ramipril—type 1 diabetes mellitus	0.00624	0.011	CcSEcCtD
Terazosin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00618	0.0109	CcSEcCtD
Terazosin—Angioedema—Ramipril—type 1 diabetes mellitus	0.00609	0.0107	CcSEcCtD
Terazosin—Malaise—Ramipril—type 1 diabetes mellitus	0.00601	0.0106	CcSEcCtD
Terazosin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00599	0.0105	CcSEcCtD
Terazosin—Syncope—Ramipril—type 1 diabetes mellitus	0.00598	0.0105	CcSEcCtD
Terazosin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00589	0.0104	CcSEcCtD
Terazosin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00586	0.0103	CcSEcCtD
Terazosin—Cough—Ramipril—type 1 diabetes mellitus	0.00582	0.0102	CcSEcCtD
Terazosin—Convulsion—Ramipril—type 1 diabetes mellitus	0.00577	0.0102	CcSEcCtD
Terazosin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00567	0.00998	CcSEcCtD
Terazosin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00567	0.00998	CcSEcCtD
Terazosin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00567	0.00998	CcSEcCtD
Terazosin—Anxiety—Ramipril—type 1 diabetes mellitus	0.00565	0.00995	CcSEcCtD
Terazosin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00561	0.00986	CcSEcCtD
Terazosin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00555	0.00976	CcSEcCtD
Terazosin—Confusional state—Ramipril—type 1 diabetes mellitus	0.00548	0.00965	CcSEcCtD
Terazosin—Oedema—Ramipril—type 1 diabetes mellitus	0.00544	0.00957	CcSEcCtD
Terazosin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00544	0.00957	CcSEcCtD
Terazosin—Shock—Ramipril—type 1 diabetes mellitus	0.00535	0.00942	CcSEcCtD
Terazosin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00533	0.00937	CcSEcCtD
Terazosin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00531	0.00934	CcSEcCtD
Terazosin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00526	0.00925	CcSEcCtD
Terazosin—Anorexia—Ramipril—type 1 diabetes mellitus	0.00519	0.00912	CcSEcCtD
Terazosin—Hypotension—Ramipril—type 1 diabetes mellitus	0.00508	0.00894	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00496	0.00872	CcSEcCtD
Terazosin—Insomnia—Ramipril—type 1 diabetes mellitus	0.00492	0.00866	CcSEcCtD
Terazosin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00488	0.00859	CcSEcCtD
Terazosin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00485	0.00853	CcSEcCtD
Terazosin—Somnolence—Ramipril—type 1 diabetes mellitus	0.00484	0.00851	CcSEcCtD
Terazosin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00479	0.00842	CcSEcCtD
Terazosin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00473	0.00832	CcSEcCtD
Terazosin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00469	0.00825	CcSEcCtD
Terazosin—Constipation—Ramipril—type 1 diabetes mellitus	0.00465	0.00818	CcSEcCtD
Terazosin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00448	0.00789	CcSEcCtD
Terazosin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00445	0.00783	CcSEcCtD
Terazosin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0043	0.00757	CcSEcCtD
Terazosin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0043	0.00757	CcSEcCtD
Terazosin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00401	0.00705	CcSEcCtD
Terazosin—Asthenia—Ramipril—type 1 diabetes mellitus	0.0039	0.00687	CcSEcCtD
Terazosin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00385	0.00677	CcSEcCtD
Terazosin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00372	0.00655	CcSEcCtD
Terazosin—Dizziness—Ramipril—type 1 diabetes mellitus	0.0036	0.00633	CcSEcCtD
Terazosin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00346	0.00609	CcSEcCtD
Terazosin—Rash—Ramipril—type 1 diabetes mellitus	0.00343	0.00603	CcSEcCtD
Terazosin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00343	0.00603	CcSEcCtD
Terazosin—Headache—Ramipril—type 1 diabetes mellitus	0.00341	0.006	CcSEcCtD
Terazosin—Nausea—Ramipril—type 1 diabetes mellitus	0.00323	0.00569	CcSEcCtD
Terazosin—ADRA1B—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000597	0.00138	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000572	0.00132	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000563	0.0013	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000545	0.00126	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000534	0.00124	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00053	0.00123	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000525	0.00122	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000524	0.00121	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000522	0.00121	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000521	0.00121	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000518	0.0012	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000515	0.00119	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000508	0.00118	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000501	0.00116	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000495	0.00115	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000487	0.00113	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000484	0.00112	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000473	0.0011	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000468	0.00108	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000468	0.00108	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000467	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000466	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000463	0.00107	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00046	0.00107	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000443	0.00103	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000442	0.00102	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000441	0.00102	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.00044	0.00102	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.00044	0.00102	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00044	0.00102	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000435	0.00101	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000435	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000432	0.001	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000427	0.00099	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000423	0.000979	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000416	0.000964	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000415	0.000961	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000407	0.000943	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000406	0.000942	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000402	0.000931	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000402	0.000931	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000395	0.000914	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000394	0.000913	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000392	0.000909	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000388	0.000899	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000388	0.000899	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000387	0.000896	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000386	0.000895	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000384	0.000889	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00038	0.000879	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000369	0.000856	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000369	0.000855	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000365	0.000845	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000361	0.000836	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000357	0.000827	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000357	0.000827	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000355	0.000823	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000349	0.000808	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000345	0.000799	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000345	0.000799	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000338	0.000782	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000337	0.000782	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000328	0.000759	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000328	0.000759	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000324	0.000751	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000324	0.000751	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000323	0.000749	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000323	0.000747	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.00032	0.000742	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00032	0.000742	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000319	0.000739	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000318	0.000737	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000306	0.00071	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000306	0.000709	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.0003	0.000695	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.0003	0.000694	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000298	0.00069	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000297	0.000689	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000297	0.000687	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000296	0.000686	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000295	0.000684	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000295	0.000683	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000291	0.000674	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000289	0.000669	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000282	0.000654	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000279	0.000647	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000278	0.000644	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000276	0.00064	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000276	0.00064	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000272	0.00063	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00027	0.000626	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000269	0.000624	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000269	0.000623	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000268	0.00062	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000265	0.000613	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000264	0.000612	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000263	0.000609	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000262	0.000607	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00026	0.000602	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000254	0.000589	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000247	0.000572	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000246	0.00057	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000245	0.000568	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000243	0.000562	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00024	0.000555	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000239	0.000553	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000238	0.000551	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000235	0.000545	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000234	0.000543	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000233	0.00054	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000232	0.000537	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000231	0.000535	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00023	0.000533	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000229	0.000531	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000229	0.000531	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000228	0.000529	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000227	0.000525	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000226	0.000523	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000224	0.000519	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000223	0.000518	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000219	0.000508	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000219	0.000508	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000219	0.000506	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000218	0.000505	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000218	0.000505	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000217	0.000504	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000216	0.000499	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000213	0.000493	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000209	0.000484	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000206	0.000477	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000206	0.000477	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000205	0.000475	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000204	0.000472	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000204	0.000472	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000203	0.000471	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000199	0.000461	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000199	0.00046	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000198	0.000459	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000193	0.000448	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000191	0.000444	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SST—type 1 diabetes mellitus	0.000191	0.000444	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000191	0.000442	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000191	0.000442	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000188	0.000436	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000182	0.000422	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000181	0.000419	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000181	0.000419	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000181	0.000419	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000173	0.000402	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000172	0.000398	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000171	0.000396	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000171	0.000395	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00017	0.000393	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000167	0.000387	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000166	0.000385	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000164	0.000381	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000162	0.000375	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000161	0.000372	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000161	0.000372	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00016	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000159	0.000369	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000159	0.000368	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000158	0.000366	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000158	0.000366	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000156	0.000362	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000154	0.000357	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000152	0.000352	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000145	0.000336	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000144	0.000335	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000142	0.000328	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000141	0.000327	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000141	0.000326	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000139	0.000322	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000136	0.000316	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000133	0.000308	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000132	0.000307	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000132	0.000306	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000132	0.000306	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000132	0.000306	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000126	0.000291	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000125	0.000291	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	0.000124	0.000288	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	0.000124	0.000286	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000123	0.000286	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000122	0.000282	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000121	0.000281	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000121	0.000281	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000121	0.00028	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00012	0.000279	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00012	0.000278	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000118	0.000272	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000117	0.000272	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000115	0.000267	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00011	0.000255	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00011	0.000254	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000107	0.000248	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000106	0.000247	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000106	0.000246	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000104	0.000241	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000103	0.000238	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000102	0.000237	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000101	0.000235	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000101	0.000234	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.0001	0.000232	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.8e-05	0.000227	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.73e-05	0.000225	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	9.67e-05	0.000224	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	9.59e-05	0.000222	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.27e-05	0.000215	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.25e-05	0.000214	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.23e-05	0.000214	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.09e-05	0.000211	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.96e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.89e-05	0.000206	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.57e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	8.42e-05	0.000195	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.41e-05	0.000195	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	8.18e-05	0.00019	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	7.96e-05	0.000184	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.7e-05	0.000178	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.66e-05	0.000177	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	7.48e-05	0.000173	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.14e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	7.13e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.11e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.09e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	7.07e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.98e-05	0.000162	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.84e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.8e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.31e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.2e-05	0.000144	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	6e-05	0.000139	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.92e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.92e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.89e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.45e-05	0.000126	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.43e-05	0.000126	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.26e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.25e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.23e-05	0.000121	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	4.98e-05	0.000115	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.98e-05	0.000115	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.76e-05	0.00011	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.52e-05	0.000105	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.42e-05	0.000102	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	4.19e-05	9.71e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.02e-05	9.31e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.48e-05	8.06e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.09e-05	7.16e-05	CbGpPWpGaD
